UK Research News

Research Advancing Kentucky: Providing crucial supports for researchers

May 2, 2025, 9:08 AM

With NIH support, Katherine Hartmann describes the vital work of the UK Center for Clinical and Translational Science (CCTS) for UK researchers and Kentucky communities.

Markey clinical trials offer ‘latest and greatest’ cancer treatments

Feb 25, 2025, 7:26 AM

During a recent roundtable discussion, Zhonglin Hao and Eddy Yang shared the importance of clinical trials and how they play a significant role in changing how providers approach cancer care.

‘Behind the Blue’: Advancing clinical research with CCTS Director Katherine Hartmann

Aug 5, 2024, 7:39 AM

In this episode of " Behind the Blue", Katherine Hartmann, the new director of UK's Center for Clinical and Translational Science, discusses her research in women's health, the impetus behind translational research and science, and UK's unique position to move the work of our researchers from campus to our community.

UK Begins 1st Clinical Trial in the World for Newly Discovered Form of Dementia

Mar 16, 2022, 7:10 AM

The world’s first clinical trial for a form of dementia identified in 2019 is officially underway by researchers at the University of Kentucky's Sanders-Brown Center on Aging.

Tegan, Piper and Josie Stanifer, daughters of UK College of Nursing researcher Stacy Stanifer

Parents are 'Proud Our Daughters are Doing Their Part' in Vaccine Research Trial

Oct 12, 2021, 6:39 AM

Professor Stacy Stanifer enrolled her three daughters in the Moderna KidCOVE clinical trial to test the dosage and efficacy of the COVID-19 vaccine in children ages 6 months through 11 years old.

'Behind the Blue': Philip A. Kern Discusses UK’s Center for Clinical and Translational Science

Sep 7, 2021, 7:04 AM

On this episode of "Behind the Blue," CCTS Director Philip A. Kern, M.D., talks about the vast amount of work the center supports.

Results of Johnson & Johnson COVID-19 Vaccine Trial Announced

Feb 1, 2021, 1:44 PM

The Phase 3 randomized, double-blind, placebo-controlled clinical trial was designed to evaluate the safety and efficacy of a single vaccine dose of the Janssen investigational COVID-19 vaccine candidate versus placebo. Approximately 45,000 people participated worldwide. The combined UK, Baptist and Norton site was among the top enrolling sites in the world.

Markey Study Shows Kentucky Endometrial Cancer Patients Have Higher Rates of DACH1 Mutation

Jan 12, 2021, 8:18 AM

A new study by UK Markey Cancer Center researchers shows that DACH1 mutations are prevalent in Kentucky patients with endometrial cancer, suggesting that DACH1 may be a candidate biomarker for future trials with immunotherapy.

'Behind the Blue': Dr. Peter Nelson Discusses UK’s Leading Efforts on Alzheimer’s and Dementia Research

Nov 20, 2020, 8:27 AM

Dr. Peter Nelson, of the UK Sanders-Brown Center on Aging, has spent the last 15 years in the Commonwealth helping to lead the fight against Alzheimer’s and dementia inducing brain disease.

UK and Baptist Health Lexington, Norton Health Care Begin Recruiting Participants for Phase 3 COVID-19 Investigational Vaccine Clinical Trial

Nov 5, 2020, 11:09 AM

Janssen’s AdVac® technology was used to develop Janssen’s Ebola vaccine regimen and is the basis for its HIV, RSV and Zika vaccine candidates.

Filter News

News type

Unit

Topic

Series